FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN

ABSTRACT: BACKGROUND: Valproic acid (VPA) is a commonly used antiepileptic drug in children as well as adult population. It is widely used as a first-line agent for patients with partial or generalized epilepsy. Thrombocytopenia is one of the common side effects associatedwith VPA therapy. OBJECTIVE...

Full description

Bibliographic Details
Main Authors: Dr.Tahir Mehmood, Dr. Munazza Saleem, Syed Sajid Hussain Shah
Format: Article
Language:English
Published: University of Faisalabad 2014-12-01
Series:Journal of University Medical & Dental College
Subjects:
Online Access:http://jumdc.com/index.php/jumdc/article/view/290
_version_ 1818642854136774656
author Dr.Tahir Mehmood
Dr. Munazza Saleem
Syed Sajid Hussain Shah
author_facet Dr.Tahir Mehmood
Dr. Munazza Saleem
Syed Sajid Hussain Shah
author_sort Dr.Tahir Mehmood
collection DOAJ
description ABSTRACT: BACKGROUND: Valproic acid (VPA) is a commonly used antiepileptic drug in children as well as adult population. It is widely used as a first-line agent for patients with partial or generalized epilepsy. Thrombocytopenia is one of the common side effects associatedwith VPA therapy. OBJECTIVES: To find out the frequency of thrombocytopenia in epileptic children receiving valproate as monotherapy for more than 6 months, in POF Hospital, Wah Cantt. DESIGN: Descriptive cross-sectional study. PATIENTS AND METHODS: This study was a carried out at Neurology clinic of paediatric OPD of POF hospital Wah Cantt from January 2011 till June 2011. Eighty eight patients, 2-12 years of age with the diagnosis of epilepsy and taking valproate as monotherapy for more than 6 months in a dose of 30mg / kg or more were included in the study. The complete blood count was done and the diagnosis of thrombocytopenia was made with the platelet count less than 150 x 109/L. RESULTS: The frequency of thrombocytopenia in patients taking valproic acid as monotherapy was 19.3% and the children using higher doses of valproate were at higher risk of developing thrombocytopenia. CONCLUSION: About one fifth of the children taking valproate as monotherapy for more than 6 months in a dose of 30mg/kg or more had thrombocytopenia. The platelet count should be monitored for children receiving valproic acid especially on higher doses. Children using higher doses of valproate are at higher risk of developing thrombocytopenia.
first_indexed 2024-12-16T23:49:40Z
format Article
id doaj.art-b94dafb76b914cbe9c762f1bb0394362
institution Directory Open Access Journal
issn 2221-7827
2310-5542
language English
last_indexed 2024-12-16T23:49:40Z
publishDate 2014-12-01
publisher University of Faisalabad
record_format Article
series Journal of University Medical & Dental College
spelling doaj.art-b94dafb76b914cbe9c762f1bb03943622022-12-21T22:11:23ZengUniversity of FaisalabadJournal of University Medical & Dental College2221-78272310-55422014-12-0152FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDRENDr.Tahir Mehmood0 Dr. Munazza Saleem1 Syed Sajid Hussain Shah2Department of Paediatrics, POF Hospital Wah Cantt PakistanAssistant Professor, Paediatrics, POF Hospital, Wah CanttDepartment of Paediatrics, POF Hospital Wah Cantt PakistanABSTRACT: BACKGROUND: Valproic acid (VPA) is a commonly used antiepileptic drug in children as well as adult population. It is widely used as a first-line agent for patients with partial or generalized epilepsy. Thrombocytopenia is one of the common side effects associatedwith VPA therapy. OBJECTIVES: To find out the frequency of thrombocytopenia in epileptic children receiving valproate as monotherapy for more than 6 months, in POF Hospital, Wah Cantt. DESIGN: Descriptive cross-sectional study. PATIENTS AND METHODS: This study was a carried out at Neurology clinic of paediatric OPD of POF hospital Wah Cantt from January 2011 till June 2011. Eighty eight patients, 2-12 years of age with the diagnosis of epilepsy and taking valproate as monotherapy for more than 6 months in a dose of 30mg / kg or more were included in the study. The complete blood count was done and the diagnosis of thrombocytopenia was made with the platelet count less than 150 x 109/L. RESULTS: The frequency of thrombocytopenia in patients taking valproic acid as monotherapy was 19.3% and the children using higher doses of valproate were at higher risk of developing thrombocytopenia. CONCLUSION: About one fifth of the children taking valproate as monotherapy for more than 6 months in a dose of 30mg/kg or more had thrombocytopenia. The platelet count should be monitored for children receiving valproic acid especially on higher doses. Children using higher doses of valproate are at higher risk of developing thrombocytopenia.http://jumdc.com/index.php/jumdc/article/view/290valproic acidplatelet countthrombocytopeniaepilepsy
spellingShingle Dr.Tahir Mehmood
Dr. Munazza Saleem
Syed Sajid Hussain Shah
FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
Journal of University Medical & Dental College
valproic acid
platelet count
thrombocytopenia
epilepsy
title FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
title_full FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
title_fullStr FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
title_full_unstemmed FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
title_short FREQUENCY OF VALPROATE INDUCED THROMBOCYTOPENIA IN EPILEPTIC CHILDREN
title_sort frequency of valproate induced thrombocytopenia in epileptic children
topic valproic acid
platelet count
thrombocytopenia
epilepsy
url http://jumdc.com/index.php/jumdc/article/view/290
work_keys_str_mv AT drtahirmehmood frequencyofvalproateinducedthrombocytopeniainepilepticchildren
AT drmunazzasaleem frequencyofvalproateinducedthrombocytopeniainepilepticchildren
AT syedsajidhussainshah frequencyofvalproateinducedthrombocytopeniainepilepticchildren